Amdocs stock trades at USD 59.50 as valuation faces pressure

Amdocs Ltd. (GB0022569080) traded at USD 59.50 on Nasdaq on September 22, 2026, according to the latest quoted market snapshot. The price was down 8.6 percent over six months, while the S&P 500 gained 16.2 percent over the same period, making relative performance the clearest current issue for Amdocs stock.

Valuation stays below eight times

The same September 22, 2026 market assessment placed Amdocs at 7.5 times forward earnings. That multiple gives the stock a lower valuation benchmark than many large technology shares, but the discount also reflects the 8.6 percent six-month decline and the 16.2 percent gain recorded by the S&P 500 during the comparison period.

According to Yahoo Finance on September 22, 2026, the share price was USD 59.50 and the six-month performance was a loss of 8.6 percent. The comparison with the S&P 500, up 16.2 percent, puts Amdocs 24.8 percentage points behind the broad benchmark.

Performance gap drives the debate

The numerical gap matters more than the headline multiple. A 7.5 times forward P/E can attract value-oriented attention, yet the market has still marked the shares 8.6 percent lower over six months while the benchmark advanced 16.2 percent.

For investors, the central question is whether the low valuation reflects a temporary earnings disconnect or a weaker growth profile. The September 22, 2026 assessment describes the recent share performance as disappointing, but it does not provide a new quarterly revenue, profit or guidance figure that can be used as a current operating catalyst.

Stock remains at USD 59.50

Amdocs stock stood at USD 59.50 on Nasdaq on September 22, 2026. The dated price, the 7.5 times forward P/E and the 24.8 percentage-point performance gap versus the S&P 500 define the current market picture.

More news and analyses on Amdocs stock